Sepsis-induced changes in macrophage co-stimulatory molecule expression: CD86 as a regulator of anti-inflammatory

Sarah Newton1, Yanli Ding, Chun-Shiang Chung

  • 1Division of Surgical Research, Department of Surgery, Lifespan/Rhode Island Hospital, Brown University School of Medicine, Providence, RI 02903, USA.

Surgical Infections
|March 4, 2005
PubMed
Abstract

Insights

Sepsis decreases CD86 and MHC II expression on macrophages, impacting immune response. CD86 deficiency prevents sepsis-induced IL-10 increase, suggesting its role in immune dysfunction.

Area of Science:

  • Immunology
  • Cell Biology
  • Sepsis Research

Background:

  • Sepsis and trauma cause immune suppression, partly due to macrophage dysfunction.
  • Reduced antigen presentation and MHC class II expression on macrophages are known sepsis effects.
  • The role of co-stimulatory receptor expression changes in sepsis-induced immune suppression is unclear.

Purpose of the Study:

  • To investigate alterations in CD40, CD80, and CD86 expression on macrophages during sepsis.
  • To determine the contribution of altered co-stimulatory receptor expression to sepsis response using knockout mice.

Main Methods:

  • Mice underwent cecal ligation and puncture (CLP) or other injury models.
  • Peritoneal, splenic, and liver macrophages were isolated 24 hours post-insult.
  • Flow cytometry analyzed ex vivo expression of CD40, CD80, CD86, and MHC II.

Main Results:

  • Sepsis and injury decreased CD86 and MHC II on peritoneal macrophages but not CD40 or CD80.
  • CD40 expression increased on Kupffer cells (liver macrophages) post-sepsis.
  • Splenic macrophages showed no significant changes in CD40, CD80, or CD86 expression.
  • Septic CD86 knockout mice did not exhibit increased IL-10 serum levels or peritoneal macrophage release.

Conclusions:

  • CD86/B7-2 plays a role beyond T-cell antigen presentation, regulating the anti-inflammatory IL-10 response.
  • This CD86-mediated IL-10 regulation may contribute to sepsis-induced immune dysfunction.